164 related articles for article (PubMed ID: 12228243)
1. Molecular characterization of a metastatic neuroendocrine cell cancer arising in the prostates of transgenic mice.
Hu Y; Ippolito JE; Garabedian EM; Humphrey PA; Gordon JI
J Biol Chem; 2002 Nov; 277(46):44462-74. PubMed ID: 12228243
[TBL] [Abstract][Full Text] [Related]
2. RNA interference of achaete-scute homolog 1 in mouse prostate neuroendocrine cells reveals its gene targets and DNA binding sites.
Hu Y; Wang T; Stormo GD; Gordon JI
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5559-64. PubMed ID: 15060276
[TBL] [Abstract][Full Text] [Related]
3. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine differentiation in the 12T-10 transgenic prostate mouse model mimics endocrine differentiation of pancreatic beta cells.
Gupta A; Wang Y; Browne C; Kim S; Case T; Paul M; Wills ML; Matusik RJ
Prostate; 2008 Jan; 68(1):50-60. PubMed ID: 18004726
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
[TBL] [Abstract][Full Text] [Related]
6. Mash1 expression is induced in neuroendocrine prostate cancer upon the loss of Foxa2.
Gupta A; Yu X; Case T; Paul M; Shen MM; Kaestner KH; Matusik RJ
Prostate; 2013 May; 73(6):582-9. PubMed ID: 23060003
[TBL] [Abstract][Full Text] [Related]
7. A transgenic mouse model of metastatic carcinoma involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotype.
Syder AJ; Karam SM; Mills JC; Ippolito JE; Ansari HR; Farook V; Gordon JI
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4471-6. PubMed ID: 15070742
[TBL] [Abstract][Full Text] [Related]
8. Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines.
Baptista MJ; O'Farrell C; Daya S; Ahmad R; Miller DW; Hardy J; Farrer MJ; Cookson MR
J Neurochem; 2003 May; 85(4):957-68. PubMed ID: 12716427
[TBL] [Abstract][Full Text] [Related]
9. Morphometric analysis of CC10-hASH1 transgenic mouse lung: a model for bronchiolization of alveoli and neuroendocrine carcinoma.
Linnoila RI; Sahu A; Miki M; Ball DW; DeMayo FJ
Exp Lung Res; 2000 Dec; 26(8):595-615. PubMed ID: 11195458
[TBL] [Abstract][Full Text] [Related]
10. Sequential induction of embryonic and adult forms of glutamic acid decarboxylase during in vitro-induced neurogenesis in cloned neuroectodermal cell-line, NE-7C2.
Varju P; Katarova Z; Madarász E; Szabó G
J Neurochem; 2002 Feb; 80(4):605-15. PubMed ID: 11841568
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promoting factors.
Rolletschek A; Chang H; Guan K; Czyz J; Meyer M; Wobus AM
Mech Dev; 2001 Jul; 105(1-2):93-104. PubMed ID: 11429285
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of Mash1 improves the GABAergic differentiation of bone marrow mesenchymal stem cells in vitro.
Wang K; Long Q; Jia C; Liu Y; Yi X; Yang H; Fei Z; Liu W
Brain Res Bull; 2013 Oct; 99():84-94. PubMed ID: 24144723
[TBL] [Abstract][Full Text] [Related]
13. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.
Westerman BA; Neijenhuis S; Poutsma A; Steenbergen RD; Breuer RH; Egging M; van Wijk IJ; Oudejans CB
Clin Cancer Res; 2002 Apr; 8(4):1082-6. PubMed ID: 11948117
[TBL] [Abstract][Full Text] [Related]
14. Mammalian achaete-scute and atonal homologs regulate neuronal versus glial fate determination in the central nervous system.
Tomita K; Moriyoshi K; Nakanishi S; Guillemot F; Kageyama R
EMBO J; 2000 Oct; 19(20):5460-72. PubMed ID: 11032813
[TBL] [Abstract][Full Text] [Related]
15. An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers.
Ippolito JE; Xu J; Jain S; Moulder K; Mennerick S; Crowley JR; Townsend RR; Gordon JI
Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9901-6. PubMed ID: 15998737
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic differentiation of human embryonic stem cells.
Zeng X; Cai J; Chen J; Luo Y; You ZB; Fotter E; Wang Y; Harvey B; Miura T; Backman C; Chen GJ; Rao MS; Freed WJ
Stem Cells; 2004; 22(6):925-40. PubMed ID: 15536184
[TBL] [Abstract][Full Text] [Related]
17. Restricted expression of a novel murine atonal-related bHLH protein in undifferentiated neural precursors.
Gradwohl G; Fode C; Guillemot F
Dev Biol; 1996 Nov; 180(1):227-41. PubMed ID: 8948587
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
Littlepage LE; Sternlicht MD; Rougier N; Phillips J; Gallo E; Yu Y; Williams K; Brenot A; Gordon JI; Werb Z
Cancer Res; 2010 Mar; 70(6):2224-34. PubMed ID: 20215503
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons.
Smits SM; Ponnio T; Conneely OM; Burbach JP; Smidt MP
Eur J Neurosci; 2003 Oct; 18(7):1731-8. PubMed ID: 14622207
[TBL] [Abstract][Full Text] [Related]
20. Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons.
Chung S; Sonntag KC; Andersson T; Bjorklund LM; Park JJ; Kim DW; Kang UJ; Isacson O; Kim KS
Eur J Neurosci; 2002 Nov; 16(10):1829-38. PubMed ID: 12453046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
